Merck Forecasts Global Molnupiravir Revenues Of $5bn-$7bn Through 2022

 
• By Jessica Merrill

Assuming emergency use authorization of the antiviral to fight COVID-19 in December, Merck expects to make $500m-$1bn this year. It will share profits equally with partner Ridgeback.

US dollars
Merck forecast billions in revenue coming from molnupiravir • Source: Alamy

More from Earnings

More from Business